CStone Pharmaceuticals (FRA:PH4)
Germany · Delayed Price · Currency is EUR 0.6600
-0.0150 (-2.22%)
At close: Nov 28, 2025
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of €931.81 million as of December 2, 2025. Its market cap has increased by 210.64% in one year.
Market Cap
931.81M
Enterprise Value
895.66M
Revenue
24.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.66
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 1.42B to 931.81M, a decrease of -34.31%. That is a compound annual growth rate of -6.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 934.53M | 155.97% |
| Dec 31, 2024 | 365.09M | 9.00% |
| Dec 29, 2023 | 334.93M | -49.41% |
| Dec 30, 2022 | 662.04M | -39.03% |
| Dec 31, 2021 | 1.09B | -11.19% |
| Dec 31, 2020 | 1.22B | 2.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |